 |
|
| Blog results | Results 1 - 10 of about 48,956 for multiple sclerosis clinical trials. (0.22 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | BioMS Medical | A Canadian Biotechnology Company - http://www.biomsmedical.com/ This Is MS | Multiple Sclerosis Research, News, and Support Community - http://www.thisisms.com/ Multiple Sclerosis :: Main Page - http://multiplesclerosis.blogharbor.com/ Multiple Sclerosis Resource Centre Latest MS News - http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=2479 Multiple Sclerosis & Life - http://sofija.wordpress.com/ | |
| 14 Dec 2009 by David Prentice The group is now engaged in a larger, randomized clinical trial for multiple sclerosis. Edwin McClure was treated with his own adult stem cells for MS. In a previous clinical review published in the Journal of the American Medical ... FRC Blog - http://www.frcblog.com/ - References |
| 7 Dec 2009 Participants have a clinical diagnosis of Multiple Sclerosis (per the 2005; Revised McDonald Criteria; Polman, et al., 2005). Kurtzke Expanded Disability Status Scale (EDSS) ≤ 7.5. For females, non-child bearing potential or a negative ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 5 hours ago by leonardo A: In trying to find the cause and more effective treatments for a disease as complex and unpredictable as multiple sclerosis, the Society is steadfast in its commitment to pursue all promising avenues of research that can lead to improved treatments and ultimately, ... Surgical procedures for CCSVI in MS are still experimental and should be undertaken only as part of formal clinical trials that include all of the standard safeguards that are followed in such trials. ... Zangani - Investor Community - http://www.zangani.com/ |
| 8 hours ago by daveyc In september 2008 I was finally diagnosed with relapsing-remitting Multiple Sclerosis. In November I was offered the chance to be a part of a clinical trial comparing a new drug called alemtuzamab with exisiting drug - rebif interferon ... Daved and Infused - http://davedandinfused.blogspot.com/ |
| 17 Nov 2009 Galapagos initiates Nanocort Phase II clinical trial for multiple sclerosis, : Galapagos NV announced that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Bionity.COM News - http://www.bionity.com/news/e/ [ More results from Bionity.COM News ] |
| 4 Dec 2009 by nortwestern Department of Clinical Neurology, University of Oxford, Oxford, UK. This Review summarizes the natural history studies on multiple sclerosis (MS) that have evaluated prognostic factors. Reassessment of prognostic factors is warranted, as our ability to offer patients a reliable prognosis is limited, yet we rely on this knowledge to appropriately design clinical trials and interpret their results. The selection criteria for studies to review included a geographical ... BioWizard - published - http://www.biowizard.com/user.php?login=tolo1987 |
| 18 Dec 2009 by AP September 22nd, 2009 WASHINGTON - In a large-scale clinical trial in US and Canada, researchers at Rush University Medical Center are trying to find out if an over-the-counter vitamin-like substance, in high doses, can slow the progression of Parkinson's ... September 13th, 2009 WASHINGTON - A new study has found that multiple sclerosis patients taking Tysabri (Natalizumab) experienced a significant improvement in both their physical function and psychological well-being. ... Health News - http://blog.taragana.com/health/ |
| 22 Nov 2009 by Joan Ohayon Joan is an associate investigator in multiple research studies involving treatments and imaging in multiple sclerosis, along with a few studies involved with a rare chronic neurological disorder, HTLV-1 Associated Myelopathy/Tropical ... EmpowHer.com - Site Activity Feed - http://www.empowher.com/ [ More results from EmpowHer.com - Site Activity Feed ] |
| 25 Nov 2009 by Admin News reports this week have detailed the research of Canadian scientists Dr Paolo Zamboni, who is a professor of medicine at the University of Ferrara in Italy and whose wife has multiple sclerosis (MS). Dr Zamboni claims from his ... IULREN.COM - http://iulren.com/ |
| 10 Dec 2009 This double-blind study evaluated two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of patients with pseudobulbar affect (PBA) secondary to ALS or multiple sclerosis (MS). .... Secondary endpoints for this clinical trial included: 1) Center for Neurologic Study-Lability Scale (CNS-LS) score; 2) Neuropsychiatric Inventory Questionnaire (NPI-Q); 3) SF-36 Health Survey; 4) Beck Depression Inventory (BDI-II); ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
